ClearStar is a leading provider of background-check technology, strategic continues to see good growth from its Direct business and in particular from its Florida-based medical screening operation (MIS), offsetting a deliberate cut in sales into channels. Interims show 11% YoY revenue growth, on track for our FY 2018 target; however, the medical business has lower margins than background screening software, and with a growing proportion of MIS revenue in the mix, we are easing back our FY EBI
17 Sep 2018
ClearStar - Medical business delivers positive EBITDA in H1
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
ClearStar - Medical business delivers positive EBITDA in H1
- Published:
17 Sep 2018 -
Author:
Cavendish Research -
Pages:
7
ClearStar is a leading provider of background-check technology, strategic continues to see good growth from its Direct business and in particular from its Florida-based medical screening operation (MIS), offsetting a deliberate cut in sales into channels. Interims show 11% YoY revenue growth, on track for our FY 2018 target; however, the medical business has lower margins than background screening software, and with a growing proportion of MIS revenue in the mix, we are easing back our FY EBI